viSNE plot of mass cytometry derived cell populations. Image Source: “viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia, Nature Biotech.” 2013, ttp://www.c2b2.columbia.edu/danapeerlab/html/CYT/visne_figure.png Cell analysis technologies within immunology are advancing at a rapid rate and are rendering deeper data across higher volumes of cells thanks […]
A study was recently published which claimed that there is a lack of association between cardiovascular disease (CVD) and total cholesterol; the authors even went on to claim that higher levels of cholesterol may prolong life and suggest that lowering cholesterol via medication is useless. This view is not only extreme, but also garnering a lot of criticism. Statins are commonly prescribed to mitigate symptoms associated with many different disorders, such as hypertension, diabetes and peripheral artery disease (PAD). For now, the jury is out on whether or not the study carries any weight, as a substantial amount of evidence will need to be collected before physicians give up on statins.
The following is a guest post by Alan S. Louie, Ph.D., Research Director at IDC Health Insights. Companies in the life sciences are well along the path to industry transformation in the shadow of blockbuster patent expirations. Changes in the industry have been unusually dramatic and swift, resulting in core […]
In today’s globalized world, emerging markets are playing an increasingly important role. Emerging markets are countries that are right on the edge of becoming developed markets. Traditionally, the term was used to describe the four BRIC countries—Brazil, Russia, India and China—but as economic conditions in Latin America and the Asia-Pacific […]
If you’ve taken a close look at your chemical inventory lately, then you may have noticed that recently received containers feature newly designed labels. In 2012, OSHA revised its Hazard Communication Standard to align with the UN’s Globally Harmonized System of Classification and Labeling of Chemicals. As part of the new guidance, the agency released a compliance schedule and in the time since, deadlines have been reached and passed.
The following is a guest post by Dan Jones, Director of Marketing Programs, BIOVIA. At the BioIT World Conference in Boston earlier this month, vendors and customers highlighted Scientific Collaboration as a major theme in drug discovery. Interestingly, over 90% of pharma and biotech companies do not yet have a […]
The following is a guest post by Thomas Bentz, who is part of the Brand Marketing team at Dassault Systèmes. To download the solution brief for Made to Cure for BioPharma, click here. The life sciences industry is the driving force behind major medical breakthroughs and therapies that ensure public […]
The following is a guest post by Matt Hahn, Ph.D., senior VP and CTO, Dassault Systèmes BIOVIA. To view the exclusive webinar “Making Secure Scientific Collaboration Work,” click here. With the drug patent cliff continuing to cast a long shadow over biopharma, the industry is radically reinventing itself by embracing […]
The following is a guest post by Dassault Systèmes’ Adrian Stevens, Senior Manager of Modeling & Simulations and Tim Moran, Director of Product Marketing, Biologics. To view the exclusive webinar “A closer look at Dassault Systemès Designed to Cure Industry Solutions Experience,” click here. When you’re inside a maze, it’s difficult to […]
Current regulatory guidelines for the pharmaceutical industry are growing more stringent than ever, with strict adherence to quality standards taking top priority. Furthermore, the increased scrutiny shows no signs of lessening anytime soon. In recent years, the FDA has trended toward issuing more warning letters to life sciences facilities and […]